Witnessing the stock’s movement on the chart, on April 07, 2021, Acasti Pharma Inc. (NASDAQ: ACST) had a quiet start as it plunged -7.72% to $0.53. During the day, the stock rose to $0.57 and sunk to $0.52 before settling in for the price of $0.57 at the close. Taking a more long-term approach, ACST posted a 52-week range of $0.17-$1.22.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 30.30%. This publicly-traded company’s shares outstanding now amounts to $200.12 million, simultaneously with a float of $179.14 million. The organization now has a market capitalization sitting at $105.26 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7390, while the 200-day Moving Average is $0.5026.
Acasti Pharma Inc. (ACST) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Acasti Pharma Inc.’s current insider ownership accounts for 2.70%, in contrast to 2.20% institutional ownership.
Acasti Pharma Inc. (ACST) Earnings and Revenue Records
As on 11/29/2017, Multinational firm has announced its last quarter scores, in which it reported -$0.31 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.24) by -$0.07. This company achieved a return on equity of -217.64. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Acasti Pharma Inc.’s EPS increase for this current 12-month fiscal period is 30.30% and is forecasted to reach -0.35 in the upcoming year.
Acasti Pharma Inc. (NASDAQ: ACST) Trading Performance Indicators
Let’s observe the current performance indicators for Acasti Pharma Inc. (ACST). The Stock has managed to achieve an average true range (ATR) of 0.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1299.54.
In the same vein, ACST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.03, a figure that is expected to reach -0.16 in the next quarter, and analysts are predicting that it will be -0.35 at the market close of one year from today.
Technical Analysis of Acasti Pharma Inc. (ACST)
Going through the that latest performance of [Acasti Pharma Inc., ACST]. Its last 5-days volume of 7.48 million was inferior to the volume of 40.76 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 12.14% While, its Average True Range was 0.0541.
Raw Stochastic average of Acasti Pharma Inc. (ACST) in the period of the previous 100 days is set at 31.76%, which indicates a major rise in contrast to 2.68% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 62.78% that was lower than 178.09% volatility it exhibited in the past 100-days period.